CRON Share Price Performance
CA$3.50
0.81 (30.11%)
17.4% undervalued intrinsic discount
CA$4.24
Fair Value
Price CA$3.50
AnalystConsensusTarget CA$4.24
AnalystLowTarget CA$3.19
AnalystHighTarget CA$5.00
Fair ValueCA$4.24
Share Pricen/a
Cronos Group Inc. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 13 Fair Values set on narratives written by author
CRON Community Narratives
AN
Fair Value CA$4.24 17.4% undervalued intrinsic discount
GrowCo Capacity And Global Markets Will Unlock Potential
0users have liked this narrative
0users have commented on this narrative
9users have followed this narrative
AN
Fair Value CA$3.19 9.7% overvalued intrinsic discount
Regulatory Shifts In Israel And Germany Will Hinder Cannabis Growth
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
Fair Value CA$5 30.0% undervalued intrinsic discount
Global Cannabis Legalization Will Expand Wellness And Medicine Markets
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
GrowCo Capacity And Global Markets Will Unlock Potential
Key Takeaways Expanded cultivation capacity and international market access are expected to drive revenue growth and increased market diversification. Strong brand performance and a shift to higher-margin products support improved profitability and margin expansion.Read more
119
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
9users have followed this narrative
AN
CA$4.24
17.4% undervalued intrinsic discount
Fair Value
Profit Margin
11.53%
Future PE
46.53x
Price in 2029
CA$5.07
Regulatory Shifts In Israel And Germany Will Hinder Cannabis Growth
Key Takeaways Reliance on international markets and regulatory uncertainty could threaten revenue growth and add financial volatility as legal or reimbursement environments shift. Intensifying price competition, ESG scrutiny, and rising operational costs may erode margin improvements and create challenges for sustained profitability.Read more
24
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
AN
CA$3.19
9.7% overvalued intrinsic discount
Fair Value
Revenue
5.48% p.a.
Profit Margin
37.47%
Future PE
18.5x
Price in 2029
CA$3.91
Global Cannabis Legalization Will Expand Wellness And Medicine Markets
Key Takeaways Strong premium brand portfolio, international expansion, and R&D investments position Cronos for sustainable margin growth and increased global market share as cannabis normalization accelerates. Robust financial health and strategic partnerships set Cronos up as a leading consolidator with significant upside from licensing, M&A, and new revenue streams.Read more
9
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
CA$5
30.0% undervalued intrinsic discount
Fair Value
Revenue
6.58% p.a.
Profit Margin
33.52%
Future PE
31.19x
Price in 2028
CA$5.93
Trending Discussion
Recently Updated Narratives
AN
CRON: Canadian Brand Strength And Rescheduling Shift Will Support Future Upside
Fair Value: CA$4.24 17.4% undervalued intrinsic discount
9 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
CRON: Rescheduling Shift Will Expose Execution Risks And Restrain Earnings Upside
Fair Value: CA$3.19 9.7% overvalued intrinsic discount
1 followerusers have followed this narrative
0 commentsusers have commented on this narrative
1 likeusers have liked this narrative
AN
Global Cannabis Legalization Will Expand Wellness And Medicine Markets
Fair Value: CA$5 30.0% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Cronos Group Inc. Key Details
About CRON
- Founded
- n/a
- Employees
- 610
- CEO
- WebsiteView website
Cronos Group Inc., a cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally. It offers dried flowers, pre-rolls, oils, vaporizers, edibles, and tinctures under the Spinach, Lord Jones, Lit, and Peace Naturals brand names. The company is headquartered in Stayner, Canada.
